Medical Condition News

RSS

Behavior problems in children with autism can be reduced with a training program for parents

The serious behavior problems that can occur in children with autism and related conditions can be reduced with a treatment plan that includes medication combined with a structured training program for parents, according to Yale University researchers and their colleagues.

26 Nov 2009

Parent mentors can help in reducing asthma complications in minority children

UT Southwestern Medical Center researchers have found that informed adults can help families stave off complications associated with asthma. The findings, available online and in the December issue of Pediatrics, suggest that interventions by parent mentors - caregivers of asthmatic children who have received specialized topical training - can effectively reduce wheezing, asthma attacks, emergency room visits and missed adult workdays.

26 Nov 2009

Erbitux drug can reverse rare stomach disorder, report researchers

A drug used to treat colorectal cancer also can reverse a rare stomach disorder and should be considered first-line therapy for the disease, researchers at Vanderbilt University Medical Center report this week.

25 Nov 2009

Protein mutation can cause a new form of heart failure

Over the course of a lifetime, the heart pumps some 250 million liters of blood through the body. In the order to do this, the muscle fibers of the heart have to be extremely durable. The research group headed by Dr. Wolfgang Rottbauer, vice chair of the Department of Medicine III at Heidelberg University Hospital (Chairman: Prof. Dr. H. A. Katus), has discovered a protein that is responsible for the stability of the smallest muscular unit, the sarcomere.

25 Nov 2009

GNC's annual St. Jude Thanks and Giving campaign: MISSION Skincare extends support

MISSION Skincare® is proud to support GNC's efforts to raise more than $1 million for St. Jude. As part of GNC's annual St. Jude Thanks and Giving campaign, $1 from the purchase price of every MISSION Skincare's new SUPER-C(TM) Lip Balm will be donated to St. Jude. Additionally, GNC customers have the opportunity to make a $1, $5 or $10 donation at checkout at one of their 5,000+ retail locations or at GNC.com. GNC hopes to raise more than $1 million for St. Jude during their 2009 Thanks and Giving campaign.

25 Nov 2009

Tips for making holiday celebrations comfortable and enjoyable for people with hearing loss

For many of the millions of hearing impaired Americans, especially the 27 million living with untreated hearing loss, the holidays may not be all that happy, says audiologist Cindy Beyer.

25 Nov 2009

Study reveals that ghrelin can increase resistance to Parkinson's disease

Ghrelin, a hormone produced in the stomach, may be used to boost resistance to, or slow, the development of Parkinson's disease, Yale School of Medicine researchers report in a study published in a recent issue of the Journal of Neuroscience.

25 Nov 2009

Advanced radiation delivery techniques can reduce TomoTherapy treatment time

TomoTherapy Incorporated announced today that a research study published in the November 11, 2009 International Journal of Radiation Oncology * Biology * Physics -- commonly known as the Red Journal -- indicated that TomoTherapy(SM) treatment times could be reduced by up to 66 percent using advanced radiation delivery techniques.

25 Nov 2009

Foot ulcers: One of the many challenges of diabetics

Diabetics face many health challenges, and among them is the risk of developing foot ulcers.

25 Nov 2009

HPA-specific shRNA holds potential as a novel therapeutic strategy for gastric cancer

Previous studies have indicated that the heparanase (HPA) is correlated with histopathological parameters and poor prognosis of gastric cancers. Although their efficiencies in inhibiting the expression of HPA, the traditional HPA inhibitors may produce nonspecific and undesirable effects. In recent years, genetic approaches targeting HPA have been regarded as a promising alternative.

25 Nov 2009

Novel way to fight UTIs: Research into Alzheimer's disease

Research into Alzheimer's disease seems an unlikely approach to yield a better way to fight urinary tract infections (UTIs), but that's what scientists at Washington University School of Medicine in St. Louis and elsewhere recently reported.

25 Nov 2009

Roche's xCELLigence RTCA DP Instrument with CIM-Plate 16 enables real-time monitoring of cell migration

Cell migration is an important process in the development of organisms, as well as during immune surveillance and wound healing. For cancer development, the potential of cells to migrate or to grow invasively is, in addition to proliferation, the most important disease-causing factor. The inhibition of cell migration is a key target of the new anti-inflammatory therapies.

25 Nov 2009

Additional data on lubiprostone presented at the GASTRO 2009 UEGF/WCOG meeting

Sucampo Pharma Europe, Ltd., and Sucampo Pharma Americas, Inc., subsidiaries of Sucampo Pharmaceuticals, Inc., today presented additional clinical data for lubiprostone (Amitiza®) at GASTRO 2009 UEGF/WCOG, the joint meeting of the United European Gastroenterology Federation (UEGF), the World Gastroenterology Organisation (WGO), the World Organisation of Digestive Endoscopy (OMED) and the British Society of Gastroenterology (BSG), in London.

25 Nov 2009

Johnson & Johnson Focused Funding grant for research on brain cell damage in PD

‏Dr. Sarit Larisch, Head of the Cell Death Research Laboratory and senior lecturer at the University of Haifa, has been awarded the prestigious Johnson & Johnson Focused Funding grant for her research exploring the cause of brain cell damage in Parkinson's disease.

25 Nov 2009

Given Imaging's PillCam SB wireless capsule endoscopy effective in treating GI patients

Given Imaging Ltd., the global leader in patient-friendly GI diagnostic and monitoring solutions, today announced that three new studies demonstrate that PillCam® SB endoscopy has a clear impact on how physicians manage GI patients, including those patients suspected of having Crohn's disease. The studies were presented at the Gastro 2009 conference taking place in London from November 21 to 25.

25 Nov 2009

UGR researchers provide early diagnosis of ARMD and keratitis

Researchers from the UGR have provided an early diagnosis of certain ocular diseases that are very common today, such as age-related macular degeneration and keratitis, by applying an existing optical technique that, nevertheless, had never before been used for this purpose.

25 Nov 2009

Human Genome Sciences submits BLA for ZALBIN

Human Genome Sciences, Inc. today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ZALBIN™ (albinterferon alfa-2b) for the treatment of chronic hepatitis C. The BLA submission includes the results of two pivotal Phase 3 clinical trials showing that 900-mcg albinterferon alfa-2b dosed every two weeks met its primary endpoint of non-inferiority to peginterferon alfa-2a (Pegasys) dosed once each week.

25 Nov 2009

Multiple Sclerosis Society of Canada to invite research operating grant proposals related to CCSVI and MS

The Multiple Sclerosis Society of Canada announced it will request research operating grants related to chronic cerebrospinal venous insufficiency (CCSVI) and MS.

25 Nov 2009

'Suicide gene E' reduces potent drug dosage in cancer patients

Researchers at the University of Granada have found a suicide gene, called 'gene E', which leads to the death of tumour cells derived from breast, lung and colon cancer, and prevents their growth. The importance of this new gene is that its use to fight cancer can reduce the potent drugs that are currently used, so that could mean more effective treatment for cancer.

25 Nov 2009

Plasma albumin levels and cardiovascular disease risk factors influenced by common genetic components

Two indicators of liver function, glutamyl transferase (GGT) and albumin (ALB) have been implicated in the pathogenesis of atherosclerosis. It is known that the variation in the plasma level of these liver related proteins is genetically influenced.

25 Nov 2009

Medical Condition News

Behavior problems in children with autism can be reduced with a training program for parents

Parent mentors can help in reducing asthma complications in minority children

Erbitux drug can reverse rare stomach disorder, report researchers

Protein mutation can cause a new form of heart failure

GNC's annual St. Jude Thanks and Giving campaign: MISSION Skincare extends support

Tips for making holiday celebrations comfortable and enjoyable for people with hearing loss

Study reveals that ghrelin can increase resistance to Parkinson's disease

Advanced radiation delivery techniques can reduce TomoTherapy treatment time

Foot ulcers: One of the many challenges of diabetics

HPA-specific shRNA holds potential as a novel therapeutic strategy for gastric cancer

Novel way to fight UTIs: Research into Alzheimer's disease

Roche's xCELLigence RTCA DP Instrument with CIM-Plate 16 enables real-time monitoring of cell migration

Additional data on lubiprostone presented at the GASTRO 2009 UEGF/WCOG meeting

Johnson & Johnson Focused Funding grant for research on brain cell damage in PD

Given Imaging's PillCam SB wireless capsule endoscopy effective in treating GI patients

UGR researchers provide early diagnosis of ARMD and keratitis

Human Genome Sciences submits BLA for ZALBIN

Multiple Sclerosis Society of Canada to invite research operating grant proposals related to CCSVI and MS

'Suicide gene E' reduces potent drug dosage in cancer patients

Plasma albumin levels and cardiovascular disease risk factors influenced by common genetic components

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News